The need for biologics and biosimilars, increased R&D investment in the biopharmaceutical sector, and rising demand for big molecule bioanalytical testing services to aid medication development and commercialization are the primary drivers driving market revenue growth.
The global large molecule bioanalytical testing service market size was USD 1.74 Billion in 2022...